Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia.
Bacillary angiomatosis is a well-recognized infection with cutaneous and systemic manifestations caused by Bartonella henselae or Bartonella quintana and occurs in immunocompromised patients. We report a case of B. quintana bacillary angiomatosis following fludarabine-based chemotherapy for chronic lymphocytic leukaemia that was refractory to standard treatment and was complicated by lymphadenopathy and osteomyelitis.
Department of Infectious Diseases, Southern Health, 246 Clayton Road, Clayton, VIC 3168, Australia.
Natasha E
NE
Holmes
Department of Haematology, Southern Health, 246 Clayton Road, Clayton, VIC 3168, Australia.
Stephen
S
Opat
Department of Anatomical Pathology, Southern Health, 246 Clayton Road, Clayton, VIC 3168, Australia.
Anthony
A
Kelman
Department of Medicine, Monash University, Clayton, VIC 3168, Australia.|Department of Infectious Diseases, Southern Health, 246 Clayton Road, Clayton, VIC 3168, Australia.
Tony M
TM
Korman
D000368:Aged; D016917:Angiomatosis, Bacillary / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001431:Bacteriological Techniques / Q000379:methods; D018413:Bartonella quintana / Q000302:isolation & purification*; D004358:Drug Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy*; D008206:Lymphatic Diseases / Q000473:pathology; D008853:Microscopy / Q000379:methods; D010019:Osteomyelitis / Q000382:microbiology; D017211:Treatment Failure; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine